Markets
News
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev












Signal Accounts for Members
All Signal Accounts
All Contests



U.K. Trade Balance Non-EU (SA) (Oct)A:--
F: --
P: --
U.K. Trade Balance (Oct)A:--
F: --
P: --
U.K. Services Index MoMA:--
F: --
P: --
U.K. Construction Output MoM (SA) (Oct)A:--
F: --
P: --
U.K. Industrial Output YoY (Oct)A:--
F: --
P: --
U.K. Trade Balance (SA) (Oct)A:--
F: --
P: --
U.K. Trade Balance EU (SA) (Oct)A:--
F: --
P: --
U.K. Manufacturing Output YoY (Oct)A:--
F: --
P: --
U.K. GDP MoM (Oct)A:--
F: --
P: --
U.K. GDP YoY (SA) (Oct)A:--
F: --
P: --
U.K. Industrial Output MoM (Oct)A:--
F: --
P: --
U.K. Construction Output YoY (Oct)A:--
F: --
P: --
France HICP Final MoM (Nov)A:--
F: --
P: --
China, Mainland Outstanding Loans Growth YoY (Nov)A:--
F: --
P: --
China, Mainland M2 Money Supply YoY (Nov)A:--
F: --
P: --
China, Mainland M0 Money Supply YoY (Nov)A:--
F: --
P: --
China, Mainland M1 Money Supply YoY (Nov)A:--
F: --
P: --
India CPI YoY (Nov)A:--
F: --
P: --
India Deposit Gowth YoYA:--
F: --
P: --
Brazil Services Growth YoY (Oct)A:--
F: --
P: --
Mexico Industrial Output YoY (Oct)A:--
F: --
P: --
Russia Trade Balance (Oct)A:--
F: --
P: --
Philadelphia Fed President Henry Paulson delivers a speech
Canada Building Permits MoM (SA) (Oct)A:--
F: --
P: --
Canada Wholesale Sales YoY (Oct)A:--
F: --
P: --
Canada Wholesale Inventory MoM (Oct)A:--
F: --
P: --
Canada Wholesale Inventory YoY (Oct)A:--
F: --
P: --
Canada Wholesale Sales MoM (SA) (Oct)A:--
F: --
P: --
Germany Current Account (Not SA) (Oct)A:--
F: --
P: --
U.S. Weekly Total Rig CountA:--
F: --
P: --
U.S. Weekly Total Oil Rig CountA:--
F: --
P: --
Japan Tankan Large Non-Manufacturing Diffusion Index (Q4)--
F: --
P: --
Japan Tankan Small Manufacturing Outlook Index (Q4)--
F: --
P: --
Japan Tankan Large Non-Manufacturing Outlook Index (Q4)--
F: --
P: --
Japan Tankan Large Manufacturing Outlook Index (Q4)--
F: --
P: --
Japan Tankan Small Manufacturing Diffusion Index (Q4)--
F: --
P: --
Japan Tankan Large Manufacturing Diffusion Index (Q4)--
F: --
P: --
Japan Tankan Large-Enterprise Capital Expenditure YoY (Q4)--
F: --
P: --
U.K. Rightmove House Price Index YoY (Dec)--
F: --
P: --
China, Mainland Industrial Output YoY (YTD) (Nov)--
F: --
P: --
China, Mainland Urban Area Unemployment Rate (Nov)--
F: --
P: --
Saudi Arabia CPI YoY (Nov)--
F: --
P: --
Euro Zone Industrial Output YoY (Oct)--
F: --
P: --
Euro Zone Industrial Output MoM (Oct)--
F: --
P: --
Canada Existing Home Sales MoM (Nov)--
F: --
P: --
Euro Zone Total Reserve Assets (Nov)--
F: --
P: --
U.K. Inflation Rate Expectations--
F: --
P: --
Canada National Economic Confidence Index--
F: --
P: --
Canada New Housing Starts (Nov)--
F: --
P: --
U.S. NY Fed Manufacturing Employment Index (Dec)--
F: --
P: --
U.S. NY Fed Manufacturing Index (Dec)--
F: --
P: --
Canada Core CPI YoY (Nov)--
F: --
P: --
Canada Manufacturing Unfilled Orders MoM (Oct)--
F: --
P: --
Canada Manufacturing New Orders MoM (Oct)--
F: --
P: --
Canada Core CPI MoM (Nov)--
F: --
P: --
Canada Manufacturing Inventory MoM (Oct)--
F: --
P: --
Canada CPI YoY (Nov)--
F: --
P: --
Canada CPI MoM (Nov)--
F: --
P: --
Canada CPI YoY (SA) (Nov)--
F: --
P: --
Canada Core CPI MoM (SA) (Nov)--
F: --
P: --


No matching data
Latest Views
Latest Views
Trending Topics
Top Columnists
Latest Update
White Label
Data API
Web Plug-ins
Affiliate Program
View All

No data
Little-known drug manufacturer Regencell Bioscience saw its shares skyrocket on Tuesday on no apparent catalyst. However, it’s possible that the exceptionally distinct business profile — specializing in traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders — caught the attention of speculators. While TCM offers some hope for medical utility, RGC stock remains a highly speculative investment.
Heading into the final stretch of the Tuesday session, Regencell gained about 345% of equity value. Naturally, the fervor over RGC stock caused the Nasdaq to halt trading multiple times today. As of this writing, the number of forcible halts amounted to 20 occurrences.
No news item appears to be responsible for the sentiment boost. Per Fintel, the short interest sits at only 0.06% of the float, with the short interest ratio coming in at only 1.64 days to cover. It’s unlikely, then, that short-squeeze speculation sparked the lift in RGC stock. Therefore, it’s possible that interest in Regencell’s almost-unique business catalyzed the jump higher.
While the first documented practice of TCM dates back to 200 BCE, it’s rare to find publicly traded companies that specialize in the field. Aside from RGC stock, China SXT Pharmaceuticals is one of a small handful of enterprises that offer TCM products.
RGC Stock Enjoys Some Rational Basis for Optimism
To underscore the wildness of RGC stock, it’s barely profitable over the past 52 weeks. That goes to show prospective investors the magnitude of red ink that long-term stakeholders have suffered. Still, it would also be unfair to declare that Regencell and the underlying TCM practice is completely speculative.
For one thing, TCM has a long history of use. That’s not to say that the practice doesn’t generate side effects because adverse reactions have been noted. However, some patients may feel more comfortable with the natural fundamentals of traditional solutions.
In addition, preliminary research into TCM shows that such therapeutics can spark positive changes in brainwave activity, thus improving behavioral challenges such as hyperactivity, impulsivity and learning difficulties in subjects affected by attention deficit hyperactivity disorder (ADHD). Such research is aligned with Regencell’s core focus, which targets ADHD and autism spectrum disorder.
Further, the TCM market is a growing one. According to Persistence Market Research, global revenue generated by the sector landed at $28.7 billion in 2022. By 2033, the ecosystem could be worth $49.6 billion, implying a compound annual growth rate of 5.1%.
Still, it should be noted that TCM lacks rigorous standardized research and testing. Therefore, investors should approach RGC stock with extreme caution.
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
On the date of publication, Josh Enomoto did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.
A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare. Tweet him at @EnomotoMedia.
More from InvestorPlace
Shares of Comcast Corporation fell sharply during Tuesday's session after the company reported worse-than-expected second-quarter sales results.
Comcast reported second-quarter revenue decline of 2.7% year-over-year to $29.69 billion, missing the analyst consensus estimate of $30.02 billion.The company reported adjusted EPS of $1.21, beating analyst consensus estimates of $1.12, according to data from Benzinga Pro.
Comcast shares declined 6.1% to $37.12 on Tuesday.
Here are some other stocks moving in today’s mid-day session.
Gainers
Losers
Now Read This:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Shares of Telefonaktiebolaget LM Ericsson rose sharply in today's pre-market trading after the company reported better-than-expected second-quarter sales and issued guidance.
Ericsson reported a second-quarter loss of 31 cents per share, compared to year-ago earnings of 7 cents per share. The company reported quarterly sales of $5.59 billion which beat the analyst consensus estimate of $5.36 billion, according to data from Benzinga Pro.
Ericsson shares jumped 4.3% to $6.66 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
Losers
Now Read This:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Shares of The Travelers Companies, Inc. fell sharply during Wednesday’s session following first-quarter earnings.
Travelers reported a mixed first quarter, with earnings lagging analyst' expectations. Core income per share reached $4.69 from $4.11 a year ago, missing the $4.90 consensus forecast. Net income per share rose to $4.80 from $4.13 a year earlier.
Travelers shares dipped 8.1% to $205.03 on Wednesday.
Here are some other stocks moving in today's mid-day session.
Gainers
Losers
Now Read This: Discover Financial Gears Up For Q1 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Shares of INVO Bioscience, Inc. rose sharply in today’s pre-market trading after reporting fourth-quarter results.
The company said quarterly revenue surged 397% year-over-year to $1,381,754, from $278,142 in the year-ago period, according to data from Benzinga Pro.
INVO Bioscience shares jumped 73.1% to $1.35 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
Losers
Now Read This: Investor Optimism Decreases; Dow Ends 6-Session Losing Streak
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Shares of Skillsoft Corp. fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates.
Skillsoft posted adjusted loss of $3.09 per share, versus market estimates of $3.27 per share. The company’s quarterly sales came in at $137.540 million versus expectations of $141.897 million.
Skillsoft shares dipped 26.7% to $6.74 on Tuesday.
Here are some other stocks moving in today's mid-day session.
Gainers
Losers
Now Read This: Dow Gains Over 100 Points; Bank of America Posts Upbeat Profit
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
The Dow Jones Industrial Average outshone its peers on Tuesday following upbeat results from health insurer UnitedHealth, while higher Treasury yields and conflict in the Middle East kept investors on edge.
At 11:02 ET, the Dow Jones Industrial Average was up 0.13% at 37,782.74. The S&P 500 was down 0.29% at 5,047.31 and the Nasdaq Composite was down 0.23% at 15,848.449.
The top three S&P 500 (.PG.INX) percentage gainers:
** UnitedHealth Group , up 4.9%
** Morgan Stanley , up 3.6%
** Super Micro Computer , up 3.4%
The top three S&P 500 (.PL.INX) percentage losers:
** Live Nation Entertainment , down 6.5%
** Bank Of America , down 3.9%
** Northern Trust , down 3.6%
The top two NYSE (.PG.N) percentage gainers:
** Better Choice Company , up 24%
** System1 , up 9.6%
The top three NYSE (.PL.N) percentage losers:
** Skillsoft Corp , down 29.9%
** Cazoo , down 18.6%
** Annovis Bio , down 11.5%
The top three Nasdaq (.PG.O) percentage gainers:
** China SXT Pharmaceuticals , up 136.8%
** WiSA Technologies , up 94%
** Palisade Bio , up 61.4%
The top three Nasdaq (.PL.O) percentage losers:
** Kaival Brands Innovations , down 27.6%
** Siyata Mobile , down 26.8%
** Conifer Holdings , down 16.4%
** International Paper : down 1.1%
BUZZ - Rises on $7.2 bln all-share deal to buy DS Smith
** Live Nation Entertainment : down 6.5%
BUZZ - Slides on report DOJ to file antitrust suit
** UnitedHealth Group : up 4.9%
** Humana : up 2.4%
** CVS Health : up 0.5%
** Elevance Health : up 1.2%
BUZZ- US health insurers rise on UnitedHealth's upbeat Q1 profit
** Lexeo Therapeutics (LEXO.O): down 1.2%
BUZZ - Rises after receiving fast track tag for gene therapy
** Intra-Cellular Therapies : up 25%
BUZZ - Up as depression drug meets main goal of late-stage study
** Howard Hughes : down 1.8%
BUZZ - JPM cuts PT on deep discount to net asset value
** Tesla : down 2.8%
BUZZ - Shares extend losses as brokerages flag challenged near term outlook
** BioRestorative Therapies : up 21.2%
BUZZ - Up as FDA clears change to study on cell therapy
** Legend Biotech :down 4.4%
BUZZ - Slips on downbeat Q1 sales for J&J-partnered blood cancer therapy
** SilverBow Resources : down 6.2%
BUZZ - Falls after Kimmeridge withdraws takeover offer
** Rio Tinto : down 2.1%
** BHP Group : down 3.8%
** Southern Copper : down 2.2%
** Freeport-McMoRan : down 2.8%
BUZZ - Copper miners fall as stronger dollar weighs on red metal
** Ducommun : down 2.0%
BUZZ - Down after rejecting takeover bid from Albion River
** Trump Media : down 10.6%
BUZZ - Extends losses; announces TV streaming plans
** Chevron : down 0.6%
** Exxon Mobil : down 0.5%
** APA Corp : down 1.7%
** Occidental Petroleum : down 3%
** Halliburton : down 1.5%
** Baker Hughes : down 0.9%
BUZZ - US energy sector falls as crude prices dip on easing Middle East supply concerns
** Hecla Mining : down 1.5%
** Coeur Mining : down 1.8%
BUZZ - Silver miners fall as interest rate cut bets diminish
** XPO : down 2.1%
BUZZ - Benchmark raises PT on stronger operating performance, solid pricing
The 11 major S&P 500 sectors:
Communication Services |
down 0.09% |
|
Consumer Discretionary |
down 0.43% |
|
Consumer Staples |
up 0.10% |
|
Energy |
down 0.82% |
|
Financial |
down 0.60% |
|
Health |
up 0.11% |
|
Industrial |
down 0.56% |
|
Information Technology |
down 0.02% |
|
Materials |
down 0.94% |
|
Real Estate |
down 1.55% |
|
Utilities |
down 1.49% |
White Label
Data API
Web Plug-ins
Poster Maker
Affiliate Program
The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.
No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.
Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.
Not Logged In
Log in to access more features

FastBull Membership
Not yet
Purchase
Log In
Sign Up